Home/ Stocks/ PPCB

Propanc Biopharma, Inc. Common Stock

PPCB XNAS

$0.33 -0.02 (-4.48%) ▼ 15-min delayed

Open

$0.35

High

$0.40

Low

$0.33

Volume

1.99M

Market Cap

$3.36M

About Propanc Biopharma, Inc. Common Stock

Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 2 Website →

TickerDaily Coverage

Penny Stocks Under $5 Showing Explosive Moves in August 2026: Educational Analysis

Penny Stocks Marcus Rivera · Aug 31, 2026

August 2026 has been a volatile month for penny stocks, with several sub-$5 names printing...

View All Coverage →

Get PPCB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Propanc Biopharma, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.